Latest filing published 01 Oct 2026 for Legend Biotech Corp, €228k.
Filings by Corazon (Corsee) D. Sanders span 3 companies, the busiest being BeOne Medicines Ltd., Ultragenyx Pharmaceutical Inc. and Legend Biotech Corp. Between 16 June 2021 and 29 September 2026, the trades on record add up to 25 filings.
The open-market record consists of 12 sales worth €2.2M, with no purchase. Besides market trades, the filings include 11 share grants and 2 option exercises. 2026 to date brings no purchases and 2 sales.
The record was last updated on 1 October 2026 with an open-market sale (€228k) in Legend Biotech Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations